ArticleMedical & biological engineering & computing2024
A lightweight xAI approach to cervical cancer classification.
Article in Medical & biological engineering & computing, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Uncertainty-aware and interpretable deep learning in cytopathology: toward trustworthy AI-powered diagnostics.Virchows Archiv : an international journal of pathology · 2026Review
- Light-XAI: a CADx for explainable cervical cancer detection via attention-based lightweight convolutional neural networks and layer-wise feature fusion.BioData mining · 2026Article
- An explainable ensemble for diabetic retinopathy grading with a novel confidence quality factor and configurable heatmaps.Medical & biological engineering & computing · 2026Article
- Interpretable hybrid ensemble with attention-based fusion and EAOO-GA optimization for lung cancer detection.Scientific reports · 2026Article
- Explainable AI based cervical cancer prediction using FSAE feature engineering and H2O AutoML.Scientific reports · 2025Article
- A hybrid vision transformer with ensemble CNN framework for cervical cancer diagnosis.BMC medical informatics and decision making · 2025Article
- AI in Cervical Cancer Cytology Diagnostics: A Narrative Review of Cutting-Edge Studies.Bioengineering (Basel, Switzerland) · 2025Review
- Performance of artificial intelligence for diagnosing cervical intraepithelial neoplasia and cervical cancer: a systematic review and meta-analysis.EClinicalMedicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Cervical cancer is caused in the vast majority of cases by the human papilloma virus (HPV) through sexual contact and requires a specific molecular-based analysis to be detected. As an HPV vaccine is available, the incidence of cervical cancer is up to ten times higher in areas without adequate healthcare resources. In recent years, liquid cytology has been used to overcome these shortcomings and perform mass screening. In addition, classifiers based on convolutional neural networks can be developed to help pathologists diagnose the disease. However, these systems always require the final verification of a pathologist to make a final diagnosis. For this reason, explainable AI techniques are required to highlight the most significant data to the healthcare professional, as it can be used to determine the confidence in the results and the areas of the image used for classification (allowing the professional to point out the areas he/she thinks are most important and cross-check them against those detected by the system in order to create incremental learning systems). In this work, a 4-phase optimization process is used to obtain a custom deep-learning classifier for distinguishing between 4 severity classes of cervical cancer with liquid-cytology images. The final classifier obtains an accuracy over 97% for 4 classes and 100% for 2 classes with execution times under 1 s (including the final report generation). Compared to previous works, the proposed classifier obtains better accuracy results with a lower computational cost.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.